|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/095 | (2006.01) |
| C07K 14/22 | (2006.01) | ||
| C07K 14/095 | (2006.01) |
| (11) | Number of the document | 3110442 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15707351.1 |
| Date of filing the European patent application | 2015-02-27 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (86) | Number | PCT/EP2015/054174 |
| Date | 2015-02-27 |
| (87) | Number | WO 2015/128480 |
| Date | 2015-09-03 |
| (30) | Number | Date | Country code |
| 14157399 | 2014-02-28 | EP | |
| 14177566 | 2014-07-17 | EP |
| (72) |
BOTTOMLEY, Matthew, IT
MALITO, Enrico, IT
MARTINELLI, Manuele, IT
SCARSELLI, Maria, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoti meningokokinio fHbp polipeptidai |
| MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 12 | 289.00 EUR |
| 2027-02-27 |